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Abstract
To investigate the role of chronic mitochondrial dysfunction on intracellular calcium signaling, we studied basal and
stimulated cytosolic calcium levels in SH-SY5Y cells and a derived cell line devoid of mitochondrial DNA (Rho‡). Basal
cytosolic calcium levels were slightly but significantly reduced in Rho‡ cells. The impact of chronic depletion of
mitochondrial DNA was more evident following exposure of cells to carbachol, a calcium mobilizing agent. Calcium
transients generated in Rho‡ cells following application of carbachol were more rapid than those in SH-SY5Y cells. A
plateau phase of calcium recovery during calcium transients was present in SH-SY5Y cells but absent in Rho‡ cells. The rapid
calcium transients in Rho‡ cells were due, in part, to increased reliance on Na/Ca2 exchange activity at the plasma
membrane and the plateau phase in calcium recovery in SH-SY5Y cells was dependent on the presence of extracellular
calcium. We also examined whether mitochondrial DNA depletion influenced calcium responses to release of intracellular
calcium stores. Rho‡ cells showed reduced responses to the uncoupler, FCCP, and the sarcoplasmic reticulum calcium
ATPase inhibitor, thapsigargin. Acute exposure of SH-SY5Y cells to mitochondrial inhibitors did not mimic the results seen
in Rho‡ cells. These results suggest that cytosolic calcium homeostasis in this neuron-like cell line is significantly altered as a
consequence of chronic depletion of mitochondrial DNA. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Fluctuations in cytosolic calcium in£uence neuro-
nal function including the regulation of gene expres-
sion, neurotransmitter release, and apoptosis. Neu-
rons regulate cytosolic calcium by controlling
calcium £ux across the plasma membrane and by
intracellular storage. Cytosolic calcium is elevated
by calcium in£ux or by release of calcium from intra-
cellular stores. Calcium removal involves calcium ef-
£ux across the plasma membrane, uptake by intra-
cellular stores and bu¡ering by calcium binding
proteins [1].
Mitochondria shape intracellular calcium re-
sponses in multiple cell types including smooth
muscle cells and gonadotropes [2,3]. Mitochondria
may regulate the pattern of calcium transients fol-
lowing calcium in£ux and release of calcium from
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intracellular stores [1,4,5]. In many cells in the nerv-
ous system such as oligodendrocytes and dorsal root
ganglion, striatal, sympathetic, and cochlear neurons,
mitochondria also regulate the size and kinetics of
calcium transients [1,5^9]. Mitochondria are speci¢-
cally believed to accumulate calcium during eleva-
tions in cytosolic calcium limiting the size of the
calcium peak and then pass calcium back to the cy-
toplasm and endoplasmic reticulum (ER) to prolong
the transient [10].
Several functional consequences of mitochondrial
calcium uptake have been determined. In neuronal
cells, mitochondrial calcium handling regulates syn-
aptic plasticity and glutamate excitotoxicity [11,12].
Intramitochondrial calcium levels may in£uence both
protein synthesis and enzyme activity within mito-
chondria [13,14]. Finally, mitochondrial calcium up-
take is thought to be involved in mitochondrial per-
meability transition pore opening and release of
factors that trigger the apoptotic cell death pathway
[15,16].
Many previous studies have examined the mito-
chondrial role in calcium signaling using isolated mi-
tochondria or permeabilized cell preparations rather
than intact cells [15,17]. Traditional analysis of the
mitochondrial role in calcium dynamics has concen-
trated on short-term, acute pharmacological inhibi-
tion of mitochondrial calcium accumulation [1,2,7].
Such acute drug studies are limited by side e¡ects
including ATP depletion, free radical production,
and in£uences on mitochondrial membrane potential
and intracellular pH and only focus on the e¡ects of
acute reductions in mitochondrial activity on calcium
signaling [18].
SH-SY5Y neuroblastoma cells have been used as a
model system for a number of neuronal processes
including intracellular signaling pathways [19]. To
investigate the role that mitochondria play in neuro-
nal calcium dynamics, we have examined SH-SY5Y
neuroblastoma cells and a derived cell line devoid of
mitochondrial DNA (Rho‡ cells). Rho‡ cells derived
from SH-SY5Y cells were created by long-term treat-
ment with low levels of ethidium bromide [20]. These
Rho‡ cells lack oxygen utilization, have reduced pro-
duction of reactive oxygen species and reduced or
absent activity in the electron transport chain com-
plexes that have components encoded by the mito-
chondrial genome (complexes I and IV but not com-
plex II). These cells are devoid of mitochondrial
DNA but survive and proliferate if provided with
exogenous pyruvate to regulate cellular redox state
[21]. Rho‡ cells, therefore, represent a cell line char-
acterized by chronic bioenergetic compromise and
dysfunctional electron transport chain function.
In the present study, we compared calcium signal-
ing in SH-SY5Y and Rho‡ neuroblastoma cells to
understand the impact of chronic reductions in elec-
tron transport chain function on calcium homeosta-
sis in whole cells. Although basal cytosolic calcium
was only minimally reduced, the calcium transients
generated in Rho‡ cells following carbachol exposure
were signi¢cantly di¡erent from those of SH-SY5Y
cells. These observations were contrasted with
changes in SH-SY5Y cell calcium signaling following
acute exposure to uncoupler or inhibition of mito-
chondrial ATP synthase activity. Long-term de¢cits
in mitochondrial electron transport chain function
had a greater, distinct impact on calcium dynamics
than acute inhibition of mitochondrial function.
These ¢ndings suggest that compensatory mecha-
nisms may develop in cells with chronic reductions
in electron transport chain activity. Speci¢c de¢cits
in the electron transport chain (complexes I and IV)
have been associated with Parkinson’s and Alzheim-
er’s diseases, respectively [22^24]. Studies using cyto-
plasmic hybrid (cybrids) created from SH-SY5Y
Rho‡ cells and platelet-derived mitochondria from
patients have suggested that defects in the mitochon-
drial genome play a role in the pathogenesis of both
Parkinson’s and Alzheimer’s disease [25^27]. Further
studies of altered calcium homeostasis in bioenergeti-
cally compromised Rho‡ cells may provide insight
into what role mitochondrial dysfunction plays in
neurodegenerative diseases such as Parkinson’s and
Alzheimer’s disease.
2. Materials and methods
2.1. Cell culture
SH-SY5Y cells and the derived Rho‡ cell line were
a gift from the laboratory of W. Davis Parker Jr.
(Department of Neurology, University of Virginia).
SH-SY5Y cells were grown in Dulbecco’s modi¢ed
Eagle’s medium supplemented with sodium pyruvate
BBAMCR 14615 5-4-00 Cyaan Magenta Geel Zwart
T.B. Sherer et al. / Biochimica et Biophysica Acta 1496 (2000) 341^355342
(110 mg/l), streptomycin (100 Wg/ml), penicillin (100
U/ml) (Life Technologies Gibco BRL, Rockville,
MD) and 10% fetal bovine serum (FBS, Summitt
Biotechnology, Fort Collins, CO). Rho‡ cells were
grown in the same medium but supplemented with
an additional 100 Wg/ml pyruvate and 50 Wg/ml ur-
idine in order to support growth [20]. These supple-
ments may function to help regulate cellular redox
state [21]. All cultures were maintained in a humidi-
¢ed incubator containing 5% CO2 at 37‡C. For rou-
tine culture, cells were grown in 75 cm2 culture £asks
and passed roughly once per week.
2.2. Assay and sensitivity of cytochrome c oxidase
activity
Parent SH-SY5Y cells were mixed with varied pro-
portions of Rho‡ cells derived from the same cell line
at a concentration of 4.0U107 cells/ml. Activity of
cytochrome c oxidase was assayed as previously de-
scribed using 1.6^3.2U106 cells [23]. The assay con-
tained 20 mM potassium phosphate, pH 7.0, 0.2 mg
n-dodecyl L-D-maltoside, and 25 WM reduced cyto-
chrome c.
2.3. Electron microscopy
SH-SY5Y and Rho‡ cells were grown until con£u-
ent in 75 cm2 culture £asks. Culture medium was
changed 1^3 h before cells were ¢xed with 4% para-
formaldehyde and 2.5% glutaraldehyde in 0.1 M so-
dium phosphate bu¡er (pH 7.2). Fixed monolayers
were washed, scraped from the £ask surface and
transferred to microfuge tubes. The tubes were cen-
trifuged at 5000 rpm for 4 min after each solution
change. Cell pellets were post-¢xed with 2% osmium
tetroxide for 1 h, rinsed with distilled water, and
dehydrated using a graded series of acetone dilutions.
Cell pellets were embedded in epoxy resin. Thin sec-
tions were cut on a Reichert Ultracut E, stained with
uranyl acetate and lead citrate and photographed at
10 000U on a JEOL 100CX transmission electron
microscope (Central Electron Microscopy Facility,
University of Virginia). Electron micrographs were
uniformly enlarged, printed and converted to com-
puter ¢les using a £atbed scanner. The perinuclear
regions of 10 randomly selected SH-SY5Y and Rho‡
cells were analyzed. The perimeters of all mitochon-
dria in each electron micrograph were individually
traced and their areas were calculated using Scion
Image PC (Scion Corp., Frederick, MD). The data
were analyzed by SigmaStat and signi¢cance was de-
termined using the Mann^Whitney rank sum test.
2.4. Mitochondrial labeling and confocal microscopy
Mitochondria in SH-SY5Y and Rho‡ cells were
labeled with 5,5P,6,6P-tetrachloro-1,1P,3,3P-tetrameth-
yl-benzimidazol carbocyanine iodine (JC-1, Molecu-
lar Probes, Portland, OR). JC-1 is a lipophilic cati-
onic dye that can be used as a sensitive measure of
mitochondrial membrane potential. At low mem-
brane potentials, JC-1 exists as a monomer and £uo-
resces green (emission 527 nm). At high membrane
potentials or concentrations, JC-1 forms red £uores-
cent ‘J-aggregates’ (emission 590 nm) [28]. Cells were
washed with HKRB bu¡er (20 mM HEPES, 103
mM NaCl, 4.77 mM KCl, 0.5 mM CaCl2, 1.2 mM
MgCl2, 1.2 mM KH2PO4, 25 mM NaHCO3, 15 mM
glucose, pH 7.3) and incubated in 4 Wg/ml JC-1 for
10 min at 37‡C [28^30]. Cells were rinsed several
times with HKRB bu¡er prior to visualization of
£uorescence signals. Images of individual cells grow-
ing in glass-bottomed culture dishes (MatTek Corp.,
Ashland, MA) were created using an Olympus Fluo-
view confocal microscope system. One to three cells
were imaged per dish (n = 5 dishes) for SH-SY5Y and
Rho‡ cells. Ratios of J-aggregate (red) to monomer
(green) were calculated using AIS software from
Imaging Research Inc. Thirty to 60 regions of inter-
est consisting of mitochondria were analyzed from
1^3 cells from each dish. Ratios of J-aggregate
(red) to monomer (green) were compared and signi¢-
cance was determined using t-tests.
2.5. Calcium experiments
Cells were harvested and replated at subcon£uent
densities into 35 mm2 culture dishes with a glass
bottom (MatTek, Ashland, MA). After 24 h in these
dishes, cells were washed with HKRB bu¡er contain-
ing 1% fetal bovine serum (FBS). Cells were then
loaded with fura2-AM (Molecular Probes, Portland,
OR) according to the following protocol. Cells were
loaded with 8 WM fura2-AM, 0.1% pluronic F-127
(Molecular Probes, Portland, OR) and 1% FBS in
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HKRB bu¡er for 30 min at 37‡C to allow the cells to
hydrolyze the AM ester. Following the 30 min load-
ing period, cells were washed twice with HKRB bu¡-
er containing 1% FBS. Calcium experiments were
performed using Olympus Life Science Resources
Merlin Software Version 1.8 provided by Life Sci-
ence Resources (Cambridge, UK) and Olympus.
Cells were visualized with a 40U objective on an
Olympus IX70 microscope. Excitation of label in
the cells was performed at 340 nm for the calcium-
bound form of the dye and 380 nm for the calcium-
unbound form. Emission was measured at 510 nm.
Cells were excited once per second to reduce exces-
sive dye photobleaching. Basal readings were taken
20^30 s prior to exposure to either 100 WM carba-
chol, 16 WM thapsigargin (Research Biochemicals In-
ternational, Natick, MA) or 5 WM carbonyl cyanide
p-tri£uoromethoxyphenylhydrazone (FCCP). Calci-
um responses were followed for up to 500 s after a
single drug exposure. The drugs were present for the
duration of the recordings. Peak calcium levels were
determined by averaging calcium levels over a 5 s
period around the highest calcium levels and ex-
pressed as a percentage of baseline calcium for
each cell. Regions of interest were de¢ned as one
cell and ratio values were converted to calcium con-
centrations by the Merlin software based on the
Grynkiewicz equation [31];
Ca2  KdR3Rmin=Rmax3R 1
where R is the Fbound at 340nm/Funbound at 380 nm, Rmin is
ratio when all dye is free of calcium, and Rmax is
ratio when dye is saturated with calcium. Rmin was
determined using 5 mM EGTA. Rmax was deter-
mined using 7.5 WM 4-bromo-A23187 ionomycin
(Molecular Probes, Portland, OR). The Kd for
fura-2 was taken as 220 nM [27]. For pharmacolog-
ical experiments, cells were exposed to FCCP (5 WM),
oligomycin (2.5 WM) (both from Sigma, St. Louis,
MO) or 10 WM Ru360 (Calbiochem, La Jolla, CA),
a cell-permeable ruthenium red analog, for 10 min
prior to treatment with carbachol (100 WM). For ex-
periments done in Na-free medium, sodium chlo-
ride was replaced with choline chloride in the
HKRB bu¡er. Cells were incubated in Na-free me-
dium for up to 10 min before the addition of carba-
chol. For experiments done in calcium-free medium,
calcium chloride was replaced with 0.1 mM EDTA.
Cells were exposed to the calcium-free conditions
immediately prior to imaging to prevent the cells
from detaching from the culture plate. Experiments
were performed on di¡erent sub-populations of cells
derived from similar passages. Each experiment aver-
aged ¢ve to six cells per dish (8^12 dishes). Results
were averaged across all the cells studied in a partic-
ular treatment group.
2.6. Calculations of time course of calcium transients
The time course of calcium decay was studied by
expressing the peak calcium level reached as a per-
centage of baseline calcium for each cell and follow-
ing the calcium decay back toward baseline. This
protocol was used to normalize the calcium re-
sponses across treatment groups. Time 0 was set at
the time of the calcium peak following carbachol
exposure. To study multiphasic calcium decay dy-
namics, instantaneous decay slopes were calculated
based on the percentage of baseline calcium decay
graphs and a running average over 10 s intervals
was determined. Slopes were averaged across cells
in a given treatment group.
2.7. Statistical analysis
Statistical analysis used multivariate analysis of
variance. Comparisons between two variables were
done using Student’s t-tests for independent samples.
Values shown represent mean þ S.E.M. Signi¢cance
was set at P9 0.05.
3. Results
3.1. Characterization of Rho‡ cells
Rho‡ cells by de¢nition are devoid of mitochon-
drial DNA. As previously described, SH-SY5Y-de-
rived Rho‡ cells are bioenergetically compromised
because they lack oxygen utilization and have no
detectable complex I (NADH:ubiquinone oxidore-
ductase) or complex IV (cytochrome c oxidase) ac-
tivity [20]. Dilution experiments were used to evalu-
ate the level of the cytochrome c oxidase expression
in the Rho‡ cells used for this study. Known
amounts of SH-SY5Y cells were mixed with Rho‡
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cells and cytochrome c oxidase was assayed. This
assay was able to detect 1% contamination by native
SH-SY5Y cells (data not shown). Calculations
showed that the Rho‡ cells used for this study
had less than 1% of control cytochrome c oxidase
activity. Previous slot blot analysis of mitochon-
drial DNA also showed that the level of expres-
sion in 1U107 Rho‡ cells was less than 10 amol
[20].
3.2. Mitochondrial morphology
Electron microscopy was used to examine the mor-
phology of mitochondria in both cell lines (Fig. 1).
Rho‡ cells contained mitochondria that were swollen
as well as a number of relatively normal mitochon-
drial structures. The percentage of mitochondria less
than 0.05 Wm2 was slightly elevated in Rho‡ cells but
the di¡erence was not statistically signi¢cant. Both
cell lines contained mitochondria that exceeded
1 Wm2. Mitochondrial components are derived from
both the nuclear and mitochondrial genomes. It is
not surprising, therefore, that Rho‡ cells were able
to express many morphologically normal mitochon-
dria-like structures despite being devoid of mitochon-
drial DNA.
Fig. 1. Electron micrographs illustrating mitochondrial morphology in SH-SY5Y (B) and Rho‡ cells (A). N = nucleus, M = mitochon-
dria, curved arrows = swollen mitochondria. Magni¢cation = 22 000U for A and 24 000U for B.
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3.3. Mitochondrial membrane potential
We used JC-1, a membrane potential-sensitive dye,
to test whether the mitochondrial membrane poten-
tial had been altered in Rho‡ cells that were depleted
of mitochondrial DNA. Interestingly, highly ener-
gized mitochondria, marked by J-aggregate (red)
staining with JC-1, were seen primarily in mitochon-
dria in SH-SY5Y cells. Mitochondria in Rho‡ cells
contained more monomer (green) than aggregate
(red) (Fig. 2A,B). The distribution of monomer and
aggregate in SH-SY5Y and Rho‡ cells was qualita-
Fig. 2. Rho‡ cells maintain a reduced mitochondrial membrane potential. Cells were incubated for 10 min with 4 Wg/ml JC-1. Yellow
lines indicate the perimeter of the cells. (A) Rho‡ cells stained with the mitochondrial membrane potential-sensitive dye, JC-1. Some
yellow (simultaneous production of green and red) and red £uorescence can be seen but most mitochondria were labeled green after
staining with JC-1. (B) SH-SY5Y cells stained with JC-1. More high energy (red) mitochondria can be seen in SH-SY5Y cells than
Rho‡ cells. (C) Mitochondria in SH-SY5Y cells show greater ratios of JC-1 £uorescence than Rho‡ cells. Ratios in arbitrary £uores-
cence units were calculated as described in Section 2 (* denotes a statistically signi¢cant di¡erence).
BBAMCR 14615 5-4-00 Cyaan Magenta Geel Zwart
T.B. Sherer et al. / Biochimica et Biophysica Acta 1496 (2000) 341^355346
tively unchanged by varying the concentration of the
JC-1 in the incubation solution from 1 to 6.5 WM
(data not shown). Using isolated rat liver mitochon-
dria, changes in potassium ion concentration over a
range of membrane potentials appropriate for the
present experiments were correlated with the ratios
of J-aggregate (red) to monomer (green). There was a
linear relationship between JC-1 aggregate/monomer
ratios and the potassium concentration [32]. On aver-
age, mitochondria in SH-SY5Y cells exhibited a
higher JC-1 aggregate/monomer ratio in arbitrary
£uorescence units (0.514 þ 0.08, n = 3 experiments,
153 mitochondrial clusters) than mitochondria in
Rho‡ cells (0.164 þ 0.06, n = 5 experiments, 175 mito-
chondrial clusters) (Fig. 2C).
3.4. Basal cytosolic calcium regulation
Basal cytosolic calcium levels were slightly, but
signi¢cantly, decreased in Rho‡ cells. SH-SY5Y cells
had intracellular calcium levels of 88.88 þ 1.8 nM
(n = 25 dishes, 147 cells) while Rho‡ cells had
68.74 þ 1.0 nM (n = 21 dishes, 150 cells, P6 0.01).
These results suggest that the e¡ect of dysfunctional
mitochondrial electron transport on the maintenance
of basal cytosolic calcium in Rho‡ cells was limited.
Since there was only a minimal e¡ect on basal cal-
cium in Rho‡ cells, the relative importance of di¡er-
ent aspects of the calcium regulatory network to cal-
cium dynamics may become more apparent following
a calcium mobilizing event.
3.5. Calcium responses to carbachol in Rho‡ cells with
chronic mitochondrial dysfunction
We exposed SH-SY5Y and Rho‡ cells to the cal-
cium mobilizing agent, carbachol, to determine if
chronic compromise of bioenergetics and the electron
transport chain would alter calcium homeostasis.
Carbachol increased intracellular calcium primarily
through the release of calcium from intracellular
stores because the response was completely inhibited
by pre-exposure to thapsigargin (data not shown).
Rho‡ cells showed a slight, but signi¢cantly elevated
response to carbachol exposure. When the change in
calcium levels was expressed as a percentage of base-
line they were measured as 1015.4 þ 38.6% change for
Rho‡ cells (n = 9 dishes, 56 cells) vs. 843.3 þ 49.0%
change for SH-SY5Y cells (n = 9 dishes, 46 cells,
P6 0.01).
Representative calcium responses to carbachol in
SH-SY5Y and Rho‡ cells are shown in Fig. 3A. Sur-
prisingly, a signi¢cant di¡erence did exist between
SH-SY5Y and Rho‡ cells in the kinetics of the cal-
cium transients following a carbachol challenge. Dif-
ferences in the time course of calcium transients can
be seen in Fig. 3B. A plateau phase that was present
in SH-SY5Y cells was absent in Rho‡ cells. A period
of rapid calcium decay between 10 and 50 s following
the calcium peak was seen in Rho‡ cells and not in
Fig. 3. Patterns of calcium decay following a carbachol chal-
lenge. (A) Representative calcium responses to 100 WM carba-
chol added at approximately 30 s in SH-SY5Y and Rho‡ cells.
Carbachol was present for the duration of the experiment. (B)
Running slopes of calcium decay after carbachol exposure.
Running slopes of calcium decay were calculated as described
in Section 2 (* indicates periods of increased calcium decay
slopes in Rho‡ cells).
BBAMCR 14615 5-4-00 Cyaan Magenta Geel Zwart
T.B. Sherer et al. / Biochimica et Biophysica Acta 1496 (2000) 341^355 347
SH-SY5Y cells. For example, the calcium decay
slopes in SH-SY5Y cells were 35.6 þ 0.9 nM/s at
10 s following the calcium peak while the slopes
were 321.1 þ 1.5 nM/s in Rho‡ cells.
3.6. Compensatory changes in the mitochondrial and
ER stores of Rho‡ cells
Rho‡ cells were exposed acutely to 5 WM FCCP to
determine whether the amount of calcium seques-
tered in mitochondria was altered by chronic electron
transport chain dysfunction (Fig. 4A). Treatments
with similar concentrations of FCCP have been
found to cause brief, small calcium transients in these
cells [26,27]. Rho‡ cells had reduced responses to
FCCP in comparison with SH-SY5Y cells, respec-
tively expressed as a change in calcium levels from
baseline (11.01 þ 0.7 nM, n = 7 dishes, 37 cells vs.
73.5 þ 3.8 nM, n = 10 dishes, 51 cells).
Thapsigargin, an inhibitor of the sarcoplasmic re-
Fig. 4. Intracellular calcium release in SH-SY5Y cells and Rho‡
cells. (A) Rho‡ cells had a reduced response to FCCP. Basal
calcium measurements were taken for 20^30 s prior to exposure
to 5 WM FCCP. FCCP was present for the duration of the ex-
periment. (B) Rho‡ cells have a reduced response to thapsigar-
gin. Basal calcium readings were taken for 20^30 s before appli-
cation of 16 WM thapsigargin. Thapsigargin was present for the
duration of the experiment (* denotes a statistically signi¢cant
di¡erence). Results are expressed as mean þ S.E.M. across cells
in each cell line.
Fig. 5. Comparison of carbachol responses in the presence of
5 WM FCCP in SH-SY5Y and Rho‡ cells. Cells were treated
with FCCP for 10 min prior to calcium imaging. Basal calcium
measurements were taken for 20^30 s prior to the addition of
carbachol. Carbachol was present for the duration of the ex-
periment. (A) Representative calcium responses to 100 WM car-
bachol in the presence of 5 WM FCCP in SH-SY5Y and Rho‡
cells. Carbachol was added around 20^30 s. (B) Calcium peaks
were expressed as percentage baseline for each cell and followed
back toward baseline (* indicates a statistically signi¢cant dif-
ference between cell lines).
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ticulum calcium ATPase, was used to determine the
capacity of ER calcium stores. Rho‡ cells showed
reduced responses to thapsigargin. Cytosolic calcium
levels in Rho‡ cells were elevated to only 114.0 þ 7.1
nM (n = 5 dishes, 57 cells) while SH-SY5Y cells in-
creased intracellular calcium levels to 236.9 þ 20.9
nM (n = 10 dishes, 50 cells, Fig. 4B).
3.7. Contribution of the calcium regulatory network to
homeostasis in Rho‡ cells
Non-mitochondrial components of the calcium
regulatory network include the ER, Na/Ca2 ex-
change and calcium pumps. To assess the contribu-
tion of non-mitochondrial components of the calci-
um regulatory network to calcium homeostasis in
SH-SY5Y and Rho‡ cells, we compared cellular re-
sponses to carbachol in the presence of FCCP. Rep-
resentative calcium responses under these conditions
are shown in Fig. 5A. In Fig. 5B, the calcium peaks
reached following carbachol exposure were expressed
as a percentage of baseline calcium for each cell and
followed back toward baseline. FCCP exposure pre-
vented the di¡erences between SH-SY5Y and Rho‡
cells in the size of the calcium responses to carba-
chol. However, in the presence of FCCP, Rho‡ cells
still exhibited faster calcium decay kinetics than SH-
SY5Y cells. By 100 s following the calcium peak,
calcium levels in Rho‡ cells treated with carbachol
in the presence of FCCP had returned to baseline
while in SH-SY5Y cells, calcium levels remained sig-
ni¢cantly elevated above baseline. This result sug-
gests that di¡erences in calcium handling between
SH-SY5Y and Rho‡ cells may result from alterations
in the calcium regulatory network in addition to re-
duced mitochondrial calcium uptake in Rho‡ cells.
The rapid kinetics of calcium transients following
carbachol exposure in Rho‡ cells may result from
altered regulation of calcium in£ux following intra-
cellular store depletion, increased calcium bu¡ering
mechanisms, or a combination of these possibilities.
To test whether Rho‡ cells have abnormal regulation
of calcium in£ux following carbachol-induced store
depletion, SH-SY5Y cells were exposed to carbachol
in the presence of HKRB bu¡er in which calcium
chloride was replaced with 0.1 mM EDTA. Repre-
sentative experiments are shown in Fig. 6A. Under
calcium-free conditions, the time course of calcium
responses to carbachol in SH-SY5Y cells was now
comparable to Rho‡ cells, although with a slight
time shift. SH-SY5Y cells (n = 6 dishes, 40 cells)
showed faster calcium decay kinetics and lacked the
calcium decay plateau when exposed to carbachol in
calcium-free medium (Fig. 6B). Calcium responses to
carbachol were una¡ected by calcium-free conditions
in Rho‡ cells (data not shown). Altered regulation of
calcium in£ux may explain, in part, the di¡erences in
the time courses of calcium responses to carbachol
between SH-SY5Y and Rho‡ cells.
Fig. 6. Calcium in£ux regulates the time course of calcium re-
sponses to carbachol. SH-SY5Y cells were exposed to 100 WM
carbachol in the presence of medium in which extracellular cal-
cium was replaced with 0.1 mM EDTA. Cells were switched to
calcium-free medium immediately prior to calcium imaging. (A)
Representative experiments. (B) Calcium decay slopes following
exposure to carbachol were calculated as described in Section 2.
Results were averaged over all the cells studied in this treat-
ment group.
BBAMCR 14615 5-4-00 Cyaan Magenta Geel Zwart
T.B. Sherer et al. / Biochimica et Biophysica Acta 1496 (2000) 341^355 349
In addition, we used pharmacological treatments
of Rho‡ cells to determine whether Rho‡ cells had
up-regulated any calcium bu¡ering mechanisms to
account for the rapid calcium transients in these
cells. Rho‡ cells were exposed to carbachol in Na-
free medium to examine the activity of the Na/Ca2
exchanger [33,34]. Basal calcium levels were unaf-
fected, but the kinetics of calcium transients were
slowed when Rho‡ cells were stimulated with carba-
chol under Na-free conditions. Representative cal-
cium tracings are shown in Fig. 7A. The appearance
of the rapid calcium decay period was signi¢cantly
reduced (Fig. 7B) suggesting that Rho‡ cells may
have an increased reliance on Na/Ca2 exchange
activity during a calcium transient in response to
carbachol.
3.8. Calcium responses to carbachol in SH-SY5Y
after acute mitochondrial inhibition
We exposed SH-SY5Y cells to acute pharmacolog-
ical manipulations prior to treating them with carba-
chol to determine if we could mimic the results found
in Rho‡ cells. Representative experiments showing
the e¡ects of acute pharmacological treatments on
calcium responses to carbachol in SH-SY5Y cells
are shown in Fig. 8A. Addition of oligomycin
(n = 7 dishes), an ATP synthase inhibitor, did not
alter the kinetics of the calcium transients in SH-
SY5Y cells (Fig. 8B) following treatment with carba-
chol. Incubating SH-SY5Y cells with FCCP (n = 6
dishes) for 10 min prior to carbachol exposure also
did not greatly alter the time course of calcium tran-
sients (Fig. 8C). In addition, we exposed SH-SY5Y
cells to carbachol in the presence of 10 WM Ru360, a
cell-permeable inhibitor of the mitochondrial calcium
uniporter [35]. The presence of Ru360 did not in£u-
ence the kinetics of carbachol-induced calcium tran-
sients (n = 5, 41 cells) [32]. None of these treatments
in£uenced basal cytosolic calcium in SH-SY5Y cells.
These results suggest that acute inhibition of mito-
chondrial function had minimal impact on the ki-
netics of calcium transients following a carbachol
challenge in SH-SY5Y cells and did not mimic the
changes in calcium homeostasis detected in Rho‡
cells.
SH-SY5Y cells were incubated in Na-free me-
dium to test the role of the Na/Ca2 exchanger in
regulating the time course of calcium responses to
carbachol. Incubation of SH-SY5Y cells in Na-
free medium (n = 4 dishes) did not change basal in-
tracellular calcium levels nor the shape of the calci-
um transient following carbachol exposure (Fig. 8D).
These results suggest that the Na/Ca2 exchanger
may not play an important role in regulating calcium
decay kinetics in SH-SY5Y cells.
Fig. 7. E¡ect of incubating Rho‡ cells in Na-free conditions
on calcium dynamics following carbachol treatment. Cells were
incubated in Na-free medium prior to calcium imaging. Basal
calcium measurements were taken for 20^30 s prior to exposure
to carbachol in the presence of Na-free conditions. (A) Repre-
sentative experiments. (B) Running slopes of calcium decay
were calculated as described in Section 2 (* indicates reduced
calcium recovery slopes compared to untreated Rho‡ cells).
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4. Discussion
The goal of the present study was to analyze the
impact of chronic bioenergetic compromise and elec-
tron transport chain dysfunction on calcium signal-
ing in a cell line derived from SH-SY5Y neuroblas-
toma cells that lacks mitochondrial DNA. We were
interested in determining what, if any, changes oc-
curred in components of the calcium regulatory net-
work in Rho‡ cells as a consequence of this chronic
mitochondrial dysfunction (Fig. 9). Rho‡ cells lack
oxygen utilization and have little or no detectable
complex I or complex IV (cytochrome c oxidase)
activity. In comparison with parent SH-SY5Y cells,
the carbachol-induced calcium transients in Rho‡
cells were more rapid. Our observations suggest
that chronic bioenergetic compromise in Rho‡ cells
resulted in compensatory changes in calcium signal-
ing that included altered regulation of calcium in£ux
and calcium e¥ux through the Na/Ca2 exchanger.
In addition, Rho‡ cells showed reduced calcium re-
sponses to the uncoupler, FCCP, and the sarcoplas-
mic calcium ATPase inhibitor, thapsigargin. Acute
exposure of SH-SY5Y cells to uncoupler (FCCP),
oligomycin, or an inhibitor of the mitochondrial cal-
cium uniporter did not mimic the calcium transients
seen in Rho‡ cells kinetics. These results suggest that
chronic reductions in electron transport chain func-
Fig. 8. E¡ect of acute pharmacological inhibition on calcium decay kinetics in SH-SY5Y cells. Cells were exposed to inhibitors for
10 min prior to calcium imaging. After 30 s of imaging, 100 WM carbachol was added. (A) Representative calcium experiments show-
ing carbachol responses in SH-SY5Y cells in the presence of 2.5 WM oligomycin, 5 WM FCCP, or Na-free medium. (B) Calcium
decay slopes for responses of SH-SY5Y cells to 100 WM carbachol in the presence of oligomycin. (C) FCCP. (D) Na-free incubation.
Results are averaged across cells in a given treatment group.
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tion profoundly impact the regulation of calcium
transients in this neuron-like cell line.
The altered carbachol-induced calcium transients
in Rho‡ cells may result from altered mitochondrial
calcium uptake as well as compensation in the cal-
cium regulatory network (Fig. 9). Even in the pres-
ence of FCCP, Rho‡ cells showed more rapid calci-
um transients in response to carbachol when
compared with similarly treated SH-SY5Y. These re-
sults suggest that non-mitochondrial di¡erences exist
between the SH-SY5Y and Rho‡ cells. SH-SY5Y
cells exhibited a calcium plateau phase, not seen in
Rho‡ cells, that may result either from a decreased
calcium bu¡ering rate or induction of calcium in£ux
following carbachol depletion of intracellular stores.
Removal of extracellular calcium caused calcium re-
sponses to carbachol in SH-SY5Y cells to closely
mimic those seen in Rho‡ cells suggesting that the
calcium decay plateau seen in SH-SY5Y cells de-
pends on the presence of extracellular calcium. The
reduced electron transport chain function in Rho‡
cells may shape this calcium plateau phase by de-
creasing the rate of calcium in£ux [36,37]. This hy-
pothesis can be tested by direct measurements of the
activity of store-operated calcium channels following
intracellular calcium store depletion.
Additionally, di¡erences in the kinetics of calcium
transients may be due to increased calcium bu¡ering
rates in Rho‡ cells (Fig. 9). Incubation of Rho‡ cells
in Na-free medium, to test the activity of the Na/
Ca2 exchanger [33^34], attenuated the rapid recov-
ery phase following a carbachol challenge. This result
suggests that Rho‡ cells may have up-regulated plas-
ma membrane Na/Ca2 exchange activity as a re-
sult of chronic reduction in electron transport chain
function. The mechanism of altered Na/Ca2 ex-
change activity in Rho‡ cells remains to be deter-
mined. Future studies using Western blots will focus
on whether expression of the Na/Ca2 exchangers is
altered in Rho‡ cells.
Although mitochondrial function was abnormal in
Rho‡ cells they still exhibited many normal mito-
chondrial-like structures at the electron microscope
level. Mitochondria are constructed from compo-
nents that are encoded by the nucleus as well as by
the mitochondria themselves. Activity of nuclear-en-
Fig. 9. Schematic diagram illustrating components of the calcium signaling network that may be altered in Rho‡ cells. Arrows indicate
potential directional £ow of calcium ions. FCCP, a protonophore, was used to determine whether di¡erences existed in the response
to the release of mitochondrial calcium stores. Thapsigargin, an inhibitor of the sarcoplasmic reticulum calcium ATPase, was used to
determine whether di¡erences existed in the response to release of ER calcium stores. Incubation in calcium-free medium was used to
determine whether di¡erences existed in the regulation of calcium in£ux in response to a carbachol challenge. Incubation in Na-free
conditions was used to determine whether di¡erences existed in the activity of the Na/Ca2 exchanger following carbachol exposure.
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coded mitochondrial enzymes is retained in cells de-
pleted of mitochondrial DNA [38] and the mitochon-
drial DNA encodes only a limited number of pro-
teins, transfer RNAs and RNAs [39]. Therefore, it is
not surprising that the mitochondrial structures in
Rho‡ cells look relatively normal. Mitochondria in
Rho‡ cells created from human 143B osteosarcoma
cells also exhibited no gross changes in structure,
composition or function [42]. However, other lines
of Rho‡ cells created from SH-SY5Y (data not
shown) or HeLa cells [40] had more extensive
changes in mitochondrial morphology. These other
Rho‡ cell lines may exhibit more substantial changes
in calcium homeostasis than the line used for this
study.
Mitochondrial membrane potential has been
shown to in£uence calcium £ux [41]. Mitochondria
in Rho‡ cells were able to maintain a membrane
potential based on JC-1 staining, as has been re-
ported previously, through an unknown mechanism
[22]. The ratio of JC-1 aggregate/monomer was sig-
ni¢cantly reduced in Rho‡ cell mitochondria suggest-
ing that they have a reduced mitochondrial mem-
brane potential. The mitochondrial membrane
potential in 143B osteosarcoma Rho‡ cells was also
60^65 mV lower than the parent cell line [42]. Re-
duced mitochondrial membrane potentials in Rho‡
cells may play a role in the ability of mitochondria
in Rho‡ cells to accumulate calcium.
Intracellular storage of calcium may also have
been altered in Rho‡ cells. In order to determine
whether the ability of mitochondria to sequester cal-
cium was compromised in Rho‡ cells, we exposed
SH-SY5Y and Rho‡ cells to the uncoupler, FCCP
(Fig. 9). Rho‡ cells demonstrated reduced calcium
responses to FCCP. This result suggests that mito-
chondrial calcium storage was reduced in Rho‡ cell
mitochondria. However, calcium responses to FCCP
are complicated and may also re£ect additional dif-
ferences in other components of the calcium signal-
ing network such as increased plasma membrane
Na/Ca2 exchange.
Recently, it has been determined that mitochon-
drial calcium accumulation may also impact the ki-
netics of ER calcium release and/or uptake. Mito-
chondria and the ER are closely associated
anatomically and calcium cycling occurs between
the two organelles [43,44]. In addition, mitochondrial
calcium uptake regulates the magnitude of calcium
extrusion from the ER [17]. For these reasons, we
tested whether di¡erences existed between SH-
SY5Y and Rho‡ cells in the size of calcium responses
to thapsigargin, as a measure of the size of the ER
calcium store (Fig. 9). Rho‡ cells showed reduced
responses to thapsigargin that may re£ect reduced
ER calcium stores in these cells. However, the size
of calcium responses to thapsigargin also involved
calcium in£ux through store-operated calcium chan-
nels following store depletion. Inhibition of mito-
chondrial function reduces calcium in£ux through
these channels [36,37]. Since calcium was present in
the extracellular medium during the thapsigargin ex-
periments, the reduced responses to thapsigargin in
Rho‡ cells may also re£ect decreased calcium in£ux
through store-operated calcium channels. We are un-
able to di¡erentiate between these possible explana-
tions for reduced calcium responses to thapsigargin
in Rho‡ cells.
One of the most interesting results of the present
study was that acute mitochondrial inhibition did
not alter basal cytoplasmic calcium or the kinetics
of calcium transients in response to carbachol. These
results are in agreement with a study examining the
e¡ects of chronic inhibition of complex I on calcium
signaling using rotenone, a speci¢c inhibitor of com-
plex I [32]. There was no e¡ect on calcium dynamics
in these cells even after 2 weeks of complex I dys-
function. After treatment with rotenone for 18 days,
however, cells began to demonstrate abnormal calci-
um responses to carbachol [32]. Taken together,
these studies illustrate that chronic mitochondrial
dysfunction may have a more profound impact on
calcium homeostasis and other cellular processes
than acute mitochondrial inhibition.
There are some limitations to the present study.
Incubation of cells in both calcium- and Na-free
conditions may in£uence the size or regulation of
intracellular calcium stores in addition to impacting
the regulation of transmembrane calcium £uxes.
These conditions may also have other side e¡ects
on cells such as altering intracellular pH and intra-
cellular calcium stores. Our measurements concen-
trated on cytoplasmic calcium levels using fura-2
and illustrate the overall e¡ect of these treatments
on the regulation of cellular calcium homeostasis.
Future studies should utilize organelle-targeted dyes
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such as rhod-2 or fura2¡ to more closely analyze the
impact of chronic reductions in electron transport
chain function on calcium signaling in the mitochon-
dria themselves [6,17].
In summary, Rho‡ cells represent a model that can
be used to study how chronic bioenergetic compro-
mise in£uences cell function. Chronic bioenergetic
compromise and electron transport chain dysfunc-
tion, in Rho‡ cells depleted of mitochondrial DNA,
altered the regulation of calcium signaling in ways
that were distinct from the alteration that occurred
in response to acute inhibition of mitochondrial
membrane potential or ATP synthase activity.
Rho‡ cells demonstrated more rapid calcium transi-
ents following carbachol exposure due to altered reg-
ulation of transmembrane calcium £ux and intracel-
lular storage. These results suggest that Rho‡ cells
undergo adaptive changes in response to chronic bio-
energetic compromise. This and other studies of
chronic electron transport chain dysfunction [32]
may provide insight into the impact of chronic mi-
tochondrial dysfunction, such as that associated with
neurodegenerative diseases, on cellular signaling
events.
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